Rite Aid CEO appointed to Supervalu board
MINNEAPOLIS — Supervalu has appointed Rite Aid president, chairman and CEO John Standley to its board of directors, the supermarket operator said.
The company also announced the appointment of Cerberus Capital Management COO and general counsel Mark Neporent.
"I am very pleased that John and Mark have accepted positions on our board," Supervalu non-executive chairman Bob Miller said. "It is important that we have a strong board of directors with a mix of industry, financial and professional experience to draw upon. John and Mark provide tremendous knowledge and a strong understanding of the guidance and direction this board should offer Supervalu during its rebuilding process."
Standley became Rite Aid’s CEO in 2010 and was elected chairman of the retail pharmacy chain’s board in June 2012, having been named its president and COO in September 2008. He had previously served as Rite Aid’s chief administrative officer and senior EVP from 1999 to 2005, as well as serving as CEO and board member of Pathmark Stores from 2005 to 2007.
Rite Aid’s relationship with Supervalu dates back to 2010, when the two companies announced a deal to open 10 co-branded Rite Aid-Save-a-Lot stores in the Greenville, S.C., area.
Jelly Belly jelly beans digs up jewel collection
FAIRFIELD, Calif. — Jelly Belly Candy celebrated National Jelly Bean Day last week by introducing a new line of jelly beans coated with an edible, iridescent sheen.
The new Jelly Belly Jewel Collection features seven of Jelly Belly’s most popular flavors finished with the gem-inspired sheen.
The new collection includes Jewel Blueberry, Jewel Bubble Gum, Jewel Sour Apple, Jewel Cream Soda, Jewel Berry Blue, Jewel Orange and Jewel Very Cherry. An edible pearlescent coating adds a shimmer of brilliance to each bean’s color. These jelly beans make a stylish gift and are a beautiful addition to candy buffets, tasting bars and favors for weddings, showers and birthday parties, the company stated.
The Jelly Belly Jewel Collection will be available nationwide at candy stores, gourmet food, gift and specialty stores beginning in May.
Jelly Belly beans are made in more than 100 flavors. Jelly Belly beans are fat free, peanut free, dairy free, gluten free, vegetarian and OU Kosher certified.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
From top to bottom, retail pharmacy will prove pharmacist role in improving patient outcomes
Pharmacy’s value as part of an outcomes-based healthcare alignment was the highlight of the closing business presentation at the National Association of Chain Drug Stores’ 2013 Annual Meeting. And now it’s up to NACDS members to expose Congressional leaders to that value quotient on a regular basis.
That was the message shared by incoming NACDS chairman Bob Narveson. It goes to show that even as the gavel passes from the head of one of the industry’s largest pharmacy chains to one of the smaller chains, innovation in patient care is happening at all levels.
"To be successful, we’re going to have to maintain access to patients [incoming from the Affordable Care Act]," Narveson told DSN as part of a pair of exclusive video interviews. (The first video interview one can be found here.) "We’re going to have to step forward and we need to get to the point where we realize that there’s more to taking care of patients by just putting pills in a bottle" he said. "We have to get to the point where we have face to face MTM, where we’re working with our patients on their medication adherence and where we continue to drive home that and we can prove it."
And both Narveson and Thrifty White, one of DSN‘s PoweRx Players, have put their money where their mouths are. Thrifty has enrolled as many as 24,000 patients on a Medication Synchronization Program, where patients receive all their medication refills on a single day. "We have people with as many as 20 medications on Medication Synchronization," Narveson said. "It’s very difficult to maintain those pills on a regular basis," he added. "It’s programs [like these] that need to be brought forward to help impact that $290 billion [in cost associated with medication non-adherence]."
According to a study conducted by Virginia Commonwealth University in 2012, patients enrolled in the program have 3.4 to 6.1 times better adherence rates vs. people not enrolled in the program.